Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Synthesis and Evaluation of a Glutamic Acid-Modified Hpamam Complex As a Promising Versatile Gene Carrier Publisher Pubmed



Hemmati M1 ; Kazemi B2 ; Najafi F3 ; Zarebkohan A1 ; Shirkoohi R4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Medical Physics and Biomedical Engineering and Nanomedicine Department, Faculty of Medicine, Shahid Beheshti Medical University, Tehran, Iran
  2. 2. Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Institute for Color Science and Technology (ICST), Ministry of Science, Research and Technology, Tehran, Iran
  4. 4. Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Drug Targeting Published:2016


Abstract

Hyperbranched poly(amidoamine) (HPAMAM), structurally analogous to polyamidoamine dendrimer (PAMAM) dendrimers, has been suggested to be an effective carrier for gene delivery. In the present study, glutamic acid-modified hPAMAM was developed as a novel non-viral gene carrier for the first time. The hPAMAM was synthesized by using a modified one-pot method. DNA was found to be bound to hPAMAM at different weight ratios (WhPAMAM/WDNA). The resulting HPAMAM-Glu20 was able to efficiently protect the encapsulated-DNA against degradation for over 2 h. In addition to low cytotoxicity, the transfection efficiency of hPAMAM-Glu20 represented much higher (p < 0.05) than that of Lipofectamine 2000 in both MCF7 and MDA-MB231 cells. Cellular uptake of the hPAMAM-Glu20 in MDA-MB231 cells, 173.56 ± 1.37%, was significantly higher than that of MCF7 cells, 65.00 ± 1.73% (p < 0.05). The results indicated that hPAMAM-Glu20-mediated gene delivery to breast cancer cells is a feasible and effective strategy that may provide a new therapeutic avenue as a non-viral gene delivery carrier. In addition, it was found that hPAMAM-glutamic amino acid (Glu)-based gene delivery is an economical, effective and biocompatible method. © 2015 Taylor & Francis.
Related Docs
1. Synthesis of a Novel Pegdga-Coated Hpamam Complex As an Efficient and Biocompatible Gene Delivery Vector: An in Vitro and in Vivo Study, Drug Delivery (2016)
2. In Vivo Gene Delivery Mediated by Non-Viral Vectors for Cancer Therapy, Journal of Controlled Release (2020)
3. Nanofibrous Scaffolds Containing Hydroxyapatite and Microfluidic-Prepared Polyamidoamin/Bmp-2 Plasmid Dendriplexes for Bone Tissue Engineering Applications, International Journal of Nanomedicine (2020)
4. Synthesis and Characterization of a Pamam Dendrimer Nanocarrier Functionalized by Srl Peptide for Targeted Gene Delivery to the Brain, European Journal of Pharmaceutical Sciences (2015)
5. Smart Bomb As1411 Aptamer-Functionalized/Pamam Dendrimer Nanocarriers for Targeted Drug Delivery in the Treatment of Gastric Cancer, Clinical and Experimental Pharmacology and Physiology (2017)
Experts (# of related papers)
View all Related Experts
Mohsen Amini (1)
Reza Shirkoohi (1)